Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase alpha, delta, and gamma are three distinct enzymes essential for the replication and maintenance of eukaryotic genomes. DNA polymerase alpha (Pol α) initiates DNA replication by synthesizing RNA–DNA primers on single-stranded DNA[7]. DNA polymerase delta (Pol δ) is primarily responsible for lagging strand synthesis, also contributing to DNA repair, and functions with the accessory protein PCNA for processivity[6][7]. DNA polymerase gamma (Pol γ) is the primary polymerase for mitochondrial DNA replication and repair[2][3]. These enzymes, while sharing a basic catalytic mechanism, have non-redundant roles and distinct biochemical properties. Inhibiting any of these can disrupt DNA replication, making them both essential cellular targets and potential pharmacological targets for antiviral or anticancer therapies[7].
Inhibition of polymerase catalytic activity (e.g., competitive binding/inactivation by small molecule or nucleotide analogues)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase alpha, delta, and gamma (Pol α, Pol δ, Pol γ).